LOGIN  |  HOME
Company Profile Report Comparative Business Report Sales Analysis Report Price Analysis Report Earnings Analysis Report
Wright Reports > Sales Analysis Report > F > Fermiscan Holdings Limited

Fermiscan Holdings Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Fermiscan Holdings Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Fermiscan Holdings Limited. The Group's principal activitise are commercialising a non-invasive diagnostic test for the detection of breast cancer (Fermiscan) and providing diagnostic services for women with symptoms of breast disease (Sydney Breast Clinic). Operations are carried out in Australia.

Not the Report you are looking for? Click here for more browsing options.

add Premium Analyses Reports:
Purchase Reports: (Combined total)
ALL Basic Reports on this Company $39.95 + Analyses Reports $64.95
Single Sales Analysis Report $24.95    
or SUBSCRIBE for full access** to over 180,000 company reports:
Monthly Basic Subscription $59.99 + Analyses Reports $89.99
Annual Basic Subscription $600/yr + Analyses Reports $750/yr

* If a currency is not selected, the report will be delivered in the local currency of the company
** Full access limits users to 500 reports per month

PDF image view sample Single Report PDF image view sample All Basic Reports

Layout and Content of a Typical Report
Company Search:
Company Name
Ticker Symbol
Key Word Search:

Search Tips



HOME | ABOUT US | FEEDBACK | HELP | CONTENT MAP
Terms and Conditions

Web site and selected data copyright 2008 The Winthrop Corporation. All rights reserved. Selected data copyright 2008, "Worldscope/Disclosure, L.L.C., a Primark affiliate." All rights reserved.